Omega-3 LC-PUFA consumption is now recommended for women of childbearing age and during pregnancy to protect against preterm and early preterm birth: implementing this recommendation in a sustainable manner
- PMID: 39677502
- PMCID: PMC11639083
- DOI: 10.3389/fnut.2024.1502866
Omega-3 LC-PUFA consumption is now recommended for women of childbearing age and during pregnancy to protect against preterm and early preterm birth: implementing this recommendation in a sustainable manner
Abstract
Preterm birth (delivery prior to 37 weeks) appears to be rising globally, increasing the risk of a myriad of down-stream disorders which affect families, their offspring and society, including increased morbidity, mortality and economic costs. Strategies for prevention of preterm birth have therefore become a priority among healthcare providers. One proposed strategy is increased consumption of Omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs), particularly docosahexaenoic acid (DHA) (from food or supplements) in women of childbearing age and during pregnancy. It is hypothesized that Omega-3 LC-PUFAs, through several different actions, reduce the risk of early onset labor or lengthen gestation. An expert group, acting on behalf of several relevant organizations, recently published guidance based on compelling trial evidence for increased Omega-3 LC-PUFA intake to protect women of childbearing age and during pregnancy from preterm birth (PTB) and early preterm birth (ePTB). Here, we consider how this guidance can be achieved in a sustainable manner. We present data on suitable, efficacious alternatives to fish as a source of Omega-3 LC-PUFAs, so that while aiming to protect families and society against PTB and ePTB there is no increased burden on other species on our vulnerable planet. Finally, how the guidance can be implemented in practice is discussed, with consideration for those most at risk and effective ways of communicating this important message.
Keywords: maternal health; omega 3 (n-3) polyunsaturated fatty acids; pregnancy; preterm (birth); sustainable omega 3s.
Copyright © 2024 Baker, Calder, Kermack, Brown, Mustapha, Kitson-Reynolds and Garvey.
Conflict of interest statement
EJB collaborates with Natures Crops International. PCC acts as an ad hoc consultant/advisor to BASF, Danone Nutricia Research, Smartfish, dsm-firmenich, Cargill, Bunge, Fresenius Kabi, B Braun and Baxter Healthcare; has received speaking honoraria from dsm-firmenich, Fresenius Kabi and Abbott Nutrition; has received writing honoraria from Fresenius Kabi; and has graduate student support from Nestlé Institute of Health Science. JJG has received fees from Abbott Nutrition, Vertex, Lely, Two Labs holdings, Nestlé Health Science, Danone Nutricia, dsm-firmenich, Fresenius Kabi, Aymes, Wiley, DMF, Callum & James and Dr Schär. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
References
-
- Chawanpaiboon S, Vogel JP, Moller A-B, Lumbiganon P, Petzold M, Hogan D, et al. . Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. (2019) 7:e37–46. doi: 10.1016/S2214-109X(18)30451-0, PMID: - DOI - PMC - PubMed
-
- Osterman MJK, Hamilton BE, Martin JA, Driscoll AK, Valenzuela CP. Births: final data for 2021. Natl Vital Stat Rep. (2023) 72:1–53. PMID: - PubMed
Publication types
LinkOut - more resources
Full Text Sources
